Cardiac sympathetic neurotransmission scintigraphy

European Journal of Nuclear Medicine

Volumn 25, Issue 4, 1998, Pages 435-441

  Schäfers, Michael ^a   Schober, Otmar ^a   Lerch, Hartmut ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

ADRENERGIC TRANSMISSION; CONTROLLED STUDY; HEART ELECTROPHYSIOLOGY; HUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HEART; HEART DISEASES; HUMANS; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031954195     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050243     Document Type: Review

References (50)

1. James TN. Primary and secondary cardioneuropathies and their functional significance. J Am Coll Cardiol 1983; 2: 983-1002.
2. Liberthson RR, Nagel EL, Hirschman JC, et al. Pathophysiologic observations in prehospital ventricular fibrillation and sudden cardiac death. Circulation 1974; 49: 790.
3. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E. ed. Heart disease. Philadelphia: Saunders, 1997.
4. Kuweit T, Schober O. Von der Schilddrüsen-Szintigraphie zur ln-vivo-Darstellung der Signaltransduktionskaskade und darüber hinaus. Nucl Med 1996; 35: 3-4.
5. McDougall AJ, McLeod JG. Autonomic neuropathy. I. Clinical features, investigation, pathophysiology, and treatment. J Neurol Sci 1996; 137: 79-88.
6. Dae MW, O' Connell JW, Botvinick EH, Ahearn T, Yee E, Huberty JP, Mori H, Chin MC, Hattner RS, Herre JM, Munoz L. Scintigraphic assessment of regional cardie adrenergic innervation. Circulation 1989; 79: 634-644.
7. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983; 67: 787-796.
8. Sisson JC, Lynch JJ, Johnson J, Jaques S Jr, Wu D. Bolgos G, Lucchesi BR, Wieland DM: Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 1988; 116: 67-76.
9. Martins JB, Zipes DP. Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 1980; 47: 33-40.
10. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ: Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 1993; 87: 454-463.
11. Hutchins G, Zipes DP. Imaging the cardiac autonomie nervous system. In: Skorton DJ. Schelbert HR, Wolf GL. Brundage BH, eds. Marcus cardiac imaging: a companion to Braunwald's heart disease. Philadelphia: Saunders; 1996: 1052-1061.
12. van Waarde A, Elsinga PH, Anthonio RL: Study of cardiac receptor ligands by positron emission tomography. In: van der Wall EE, Blanksma PK, Niemeyer MG, Paans AMJ eds. Cardiac positron emission tomography. Dordrecht: Kluwer Academic; 1995: 171-182.
13. Visser TJ, van Waarde A, van der Mark TW. Characterization of pulmonary and myocardial beta-adrenoceptors with S-I′[fluorine-18]fluorocarazolol. J Nucl Med 1997; 38: 169-174.
14. DeGrado TR, Hutchins GD, Toorongian SA, Wieland D, Schwaiger M; Myocurdial kinetics of carbon-11-meta-nydroxyephedrine: retention mechanisms and effect of norepinephrine. J Nucl Med 1993; 34: 1287-1293.
15. Schäfers M, Dutka D, Rhodes CG, Lammertsmaa A, Hermansen F, Schober O, Camici PG. Myocardial pre-and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 1998; 82 (in press).
16. Delforge J, Syrota A, Lancon JP. Cardiac β-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991; 32: 739-748.
17. Schäfers M, Lerch H, Wichter T, Rhodes CG, Lammertsma AA, Breithardt G, Schober O. Cardiac autonomic dysfunction in patients with idiopathic ventricular tachycardia assessed by PET with C-11-CGP 12177 and C-11-hydroxyephedrine. J Nucl Med 1991; 38: 171P.
18. Lerch H, Wichter T, Schamberger R, Hindricks G, Schober O, Breithardt G: Sympathetic myocardial innervation in idiopathic ventricular tachycardia and fibrillation. Eur J Nucl Med 1995; 22: 805.
19. Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G. Kopin IJ: Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 1997; 336: 696-702.
20. Schwaiger M, Hutchins GD, Kalff V, Rosenspire K, Haka MS, Malette S, Deeb GM, Abrams CD, Wieland D. Evidence for regional catecholamine uptake and storage sites in the transplanted human heart by positron emission tomography. J Clin Invest 1991; 87: 1681-1690.
21. De Marco T, Dae M, Yuen Green MS, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol 1995; 25: 927-931.
22. Estorch M, Carrió I, Ruira X. Assessment of sympathetic cardiac re-innervation after heart transplantation. J Nucl Med 1997; 38: 111P.
23. Ziegler SI, Frey AW, Überfuhr P, Dambacher M, Watzlowik P, Nekolla S, Wieland DM, Reichart B, Schwaiger M. Assessment of myocardial re-innervation in cardiac transplants by positron emission tomography: functional significance tested by heart rate variability, Clin Sci 1996; 91 Suppl: 126-128.
24. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural infarction. J Am Coll Cardiol 1991; 17: 1416-1423.
25. Dae MW, O'Connell JW, Botvinick EH, Chin MC. Acute and chronic effects of transient myocardial ischemia on sympathetic nerve activity, density, and norepinephrine content. Cardiovasc Res 1995; 30: 270-280.
26. Allman KC, Wieland DM, Muzik O, Degrado TR, Wolfe ER, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol 1993; 22:368-375.
27. Matsuo S, Takahashi M, Nakamura Y, Kinoshita M. Evaluation of cardiac sympathetic innervation with iodine-123-meta-iodobenzylguanidine imaging in silent myocardial ischemia. J Nucl Med 1996; 37: 712-717.
28. Merlet P, Delforge J, Syrota A, Angevin E, Maziere B, Crouzel C, Valette H, Loisance D, Castaigne A, Rande JL. Positron emission tomography with 11-C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993; 87: 1169-1178.
29. Henderson EB, Kahn JK, Corbett JR. Abnormal myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive heart cardiomyopathy. Circulation 1988; 78: 1192-1199.
30. Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, Adachi I, Narabayashi I. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 1997; 133: 353-358.
31. Lefroy DC, de Sliva R, Choudhury L, Uren NG, Crake T. Rhodes CG, Lammertsma AA, Boyd H, Patsalaos PN, Nihoyannopoulos P, Oakley CM, Jones T, Camici PG. Diffuse reduction of myocardial beta adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 1993; 22: 1653-1660.
32. Choudhury L, Guzzetti S, Lefroy DC, Nihoyannopoulos P, McKenna WJ, Oakley CM, Camici PG. Myocardial β adrenoceptors and left ventricular function in hypertrophic cadiomyopathy. Heart 1996; 75: 50-55.
33. Wichter T, Lerch H, Schober O, Breithardt G. Radionuclide imaging of sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy/dysplasia. In: Thiene G, Nava A, Rossi L, eds. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Amsterdam: Elsevier Science; 1998; (in press)
34. Lerch H, Bartenstein P, Wichter T, Hindricks G, Borggrefe M, Breithardt G, Schober O. Sympathetic innervation of the left ventricle is impaired in arrhythmogenic right ventricular disease. Eur J Nucl Med 1993; 20: 207-212.
35. 123I-meta-iodobenzylguanidine scintigraphy. Circulation 1994; 89: 667-683.
36. Wichter T, Lerch H, Schäfers M, Rhodes CG, Lammertsma AA, Schober O, Breithardt G. Reduction of postsynaptic β-receptor density in arrhythmogenic right ventricular dysplasia: assessment with positron emission tomography. Circulation 1996; 94 Suppl I: I-543.
37. Kim SJ, Lee JD, Ryu YH, Jeon P, Shim YW, Yoo HS, Park CV, Lim SG. Evaluation of cardiac sympathetic neuronal intergrity in diabetic patients using iodine-123 metaiodobenzyl-guanidine. Eur J Nucl Med 1996; 23: 401-406.
38. Hattori N, Tamaki N, Hayashi T, Masuda I, Kudoh T, Tateno T, Tadamura M, Yonekura Y, Nakao K, Konishi J. Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996; 37: 1985-1990.
39. Hattori N, Masuda I, Inubushi M. Hyper-reaction against dobutamine stress in severely denervated diabetic hearts. J Nucl Med 1997; 38: 111P.
40. Morimoto S, Terada K, Keira N, Satoda M, Inoue K, Tatsukawa H, Katoh S, Ida K, Sugihara H, Takeda K, Nakagawa M. Investigation of the relationship between regression of hypertensive cardiac hypertrophy and improvement of cardiac sympathetic nervous dysfunction using iodine-123 metaiodo-benzylguanidine. Eur J Nucl Med 1996; 23: 756-761.
41. Morimitsu T, Miyahara Y, Sinboku H, Ikeda S, Naito T, Nishijima K, Takao M. Iodine-123-metaiodobenzylguanidine myocardial imaging in patients with right ventricular pressure overload. J Nucl Med 1996; 37: 1343-1346.
42. Jones T. The role of positron emission tomography within the spectrum of medical imaging. Eur J Nucl Med 1996; 23: 207-211.
43. Jones T. The imaging science of positron emission tomography. Eur J Nucl Med 1996; 23: 807-813.
44. Ben-Haim SA, Osadchy D, Schuster I, Gepstein L, Hayam G, Josephson ME. Nonfluoroscopic, in vivo navigation and mapping technology. Nature Med 1996; 2: 1393-1395.
45. Vaidyanathan G, Zhao XG, Strickland DK, Zalutsky MR. Nocarrier-added iodine-131-FIBG: evaluation of an MIBG analog. J Nucl Med 38; 1997: 330-334.
46. Volkow ND, Fowler JS, Gatley SJ, et al. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37: 1242-1256.
47. 18F]-Labeled 1,2-diacyl-glycerols; a new tracer for the imaging of second messenger system. J Labeled Radiopharm 1994; 35: 517-519.
48. Huguet F, Fagret D, Caillet M, Piriou A, Besnard JC. Guilloteau D. Interaction of metaiodobenzylguandine with cardioactive drugs: an in vitro study. Eur J Nucl Med 1996; 23: 546-549.
49. Valdes Olomos R, ten Bokkel Huinink WW. Dewit LGH, Hoefnagel CA, Liem IH. van Tinteren H. Iodine-123 meta-iodobenzylguanidine in the assessment of late cardiac effects from cancer therapy. Eur J Nucl Med 1996; 23: 453-458.
50. Wagner HJ. Commentary: molecular nuclear medicine: the best kept secret in medicine. J Nucl Med 1997; 38: 15N-17N.